Welcome to the Hepatitis B & C Public Policy Association

The Hepatitis Public Policy Association aims to urge and facilitate the formulation of public policies at national and international level for the communication, prevention and management of the spread of viral Hepatitis B and C. The Association’s unique approach in furtherance of this aim is to gather together, and work in partnership with, the major stakeholders in the field of these diseases including regulators, patients, clinicians, public health and civil society communities and the private sector.

The Association was formed in 2009 as the Hepatitis B and C Summit Conferences Association asbl [association sans but lucratif]. For further information on its organization, membership and funding please see About Us.

In October 2010 the Association organised a conference on Hepatitis B and C in Europe in Brussels under the auspices of the EU Belgian Presidency. For further information about this event including the reports launched there, please consult the Conference website page. The Call to Action launched there is available here. A full report on this conference was published in an independent supplement of the Journal of Viral Hepatitis and is freely available on their website.

In December 2012 the Association hosted a conference on Hepatitis B and C in Mediterranean and Balkan Countries in Nicosia under the auspices of the Cyprus EU Presidency. For information about its programme and presentations please consult the Conference website page. The Call to Action launched there is available in 14 languages here. The Journal of Viral Hepatitis published a full report on this conference in an independent supplement in June 2013, which is freely available on this link.

In June 2014 the Association hosted a High Level Meeting in Athens under the auspices of the Greek EU Presidency. Please see here for its programme, speakers’ presentations, and the text of the Call to Action presented there. The Journal of Viral Hepatitis will issue an independent supplement on this Meeting.

The Association’s Working Group report on Barriers to care and treatment for patients with chronic viral hepatitis in Europe was published as a systematic review article in Liver International earlier this year. Its full text is freely available using this link. [http://onlinelibrary.wiley.com/doi/10.1111/liv.12565/pdf].

HepBCPPA JOINS NEW COALITION CALLING ON EU TO TAKE ACTION TO ELIMINATE VIRAL HEPATITIS BY 2030.

Launched at an event in the European Parliament on 7 June 2017, the ACHIEVE (short for Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe) coalition calls on the EU to take action to eliminate viral hepatitis B and C by 2030 in the WHO European Region, in line with the WHO Global Health Sector Strategy on viral hepatitis, the WHO Europe Action Plan, which build on and the UN Sustainable Development Goals (SDGs). The ACHIEVE coalititon comes together to speak with one voice representing patients and community, clinicians and researchers.

The coalition includes the following organisations: the European Liver Patients’ Association (ELPA), the Viral Hepatitis Prevention Board, Hepatitis B and C Public Policy Association, EASL International Liver Foundation, European AIDS Treatment Group (EATG), Correlation Network, the World Hepatitis Alliance and the Barcelona Institute for Global Health (ISGlobal).